Views & Analysis Just how much does the NHS spend on medicines? Confidential discounts and the PPRS pricing system are making it more difficult to arrive at an accurate figure.
News Theresa May backtracks on 'Dementia tax' Parties take out rival ads as social care funding row escalates.
News Pharma underwhelmed by Conservatives' pledges on NHS funding... Prime Minister Theresa May has unveiled the Conservative’s general election manifesto, its range of policies including the promise of £8 billion extra for the NHS – but a rowing back on an
News Labour's tax rises could damage economy, says UK pharma Corporation tax increase could damage UK's competitiveness, says ABPI
News NHS cyberattack: government and Microsoft criticised as thre... Who is to blame for the vulnerability of the NHS to this attack?
Views & Analysis Digital health round-up: Make or break for Fitbit? Will Fitbit's talks with the NHS solve the ailing firm's problems?
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
